A researcher prepares a sample at BeiGene's research and development centre in Beijing on May 24, 2018. The company is opening a facility in Guangzhou late this year specifically built for large molecule biological drugs. Photo: Bloomberg A researcher prepares a sample at BeiGene's research and development centre in Beijing on May 24, 2018. The company is opening a facility in Guangzhou late this year specifically built for large molecule biological drugs. Photo: Bloomberg
A researcher prepares a sample at BeiGene's research and development centre in Beijing on May 24, 2018. The company is opening a facility in Guangzhou late this year specifically built for large molecule biological drugs. Photo: Bloomberg
Pharmaceuticals

Guangzhou offers lots of carrots to win over international biotech players in race to catch up with Beijing and Shanghai

  • Huge Sino-Singapore Guangzhou Knowledge City will foster high-tech industrial clusters
  • GE Healthcare of the US is building its first Asia biotech campus there

Topic |   Pharmaceuticals
A researcher prepares a sample at BeiGene's research and development centre in Beijing on May 24, 2018. The company is opening a facility in Guangzhou late this year specifically built for large molecule biological drugs. Photo: Bloomberg A researcher prepares a sample at BeiGene's research and development centre in Beijing on May 24, 2018. The company is opening a facility in Guangzhou late this year specifically built for large molecule biological drugs. Photo: Bloomberg
A researcher prepares a sample at BeiGene's research and development centre in Beijing on May 24, 2018. The company is opening a facility in Guangzhou late this year specifically built for large molecule biological drugs. Photo: Bloomberg
READ FULL ARTICLE